Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Abroad (travel likely)Recruiting

Conditions

Chronic Kidney Disease (Stages 4 and 5) · Kidney Disease · Type 2 Diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Arizona Kidney Disease and Hypertension Center, Phoenix, Arizona, United States
Contact: Study coordinator (Cynthia Carrizoza, MS, CCRP) · ccarrizoza@akdhc.com · 602-997-0484
Contact: Principal Investigator (Sungchun Lee, MD)

Study leads

Sungchun Lee, MD
Principal Investigator
Arizona Kidney Disease and Hypertension Centers

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients

Chronic Kidney Disease (Stages 4 and 5) · Peritoneal Dialysis (PD)

Abroad (travel likely)Recruiting

Monterrey, Mexico

Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease

Chronic Kidney Disease (Stages 4 and 5) · Health Related Quality of Life

Abroad (travel likely)Recruiting

Boston, United States

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

End Stage Chronic Renal Failure · Chronic Kidney Disease (Stages 4 and 5) · Kidney Transplantation Recipients

Abroad (travel likely)Recruiting

Nashville, United States

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

Hypertensive Nephropathy · Auto Immune Disorders · Chronic Kidney Disease

Abroad (travel likely)RecruitingPHASE4

Giza, Egypt